Abstract-Heme oxygenase (HO)-1 degrades the pro-oxidant heme and generates carbon monoxide and antioxidant bilirubin. We have previously shown that in response to hypoxia, HO-1-null mice develop infarcts in the right ventricle of their hearts and that their cardiomyocytes are damaged by oxidative stress. To test whether HO-1 protects against oxidative injury in the heart, we generated cardiac-specific transgenic mice overexpressing different levels of HO-1. By use of a Langendorff preparation, hearts from transgenic mice showed improved recovery of contractile performance during reperfusion after ischemia in an HO-1 dose-dependent manner. In vivo, myocardial ischemia and reperfusion experiments showed that infarct size was only 14.7% of the area at risk in transgenic mice compared with 56.5% in wild-type mice. Hearts from these transgenic animals had reduced inflammatory cell infiltration and oxidative damage. Our data demonstrate that overexpression of HO-1 in the cardiomyocyte protects against ischemia and reperfusion injury, thus improving the recovery of cardiac function. Key Words: heart Ⅲ infarction Ⅲ Langendorff preparation Ⅲ cytoprotection Ⅲ inflammation O xidative stress in the heart caused by ischemia and reperfusion leads to cardiomyocyte death. 1-3 Several studies have shown that increased expression of myocardial stress proteins and/or antioxidant enzymes protects against postischemic injury. 4 -6 In response to stress, elevated expression of heat shock proteins may protect the myocardium. 7 These heat shock proteins are thought to mediate cardioprotection through their biological functions as molecular chaperones by preventing protein denaturation. 7 Heme oxygenase (HO)-1, a stress response and cytoprotective protein, also known as hsp32, protects cells from death due to pathophysiological stress. 8 -12 By degrading the pro-oxidant heme and generating the antioxidant bilirubin, 13,14 HO-1 may protect cells against oxidative injury. In addition, carbon monoxide (CO), another HO-1 reaction product, contributes to the regulation of vascular tone and is reported to have antiinflammatory properties, which may contribute to the cytoprotective action of HO-1. 15,16 HO-1 is upregulated in the heart and blood vessels in response to hemodynamic stress in rats 17,18 and ischemia/ reperfusion injury in pigs, 19,20 implicating an important role for HO-1 in cardiovascular homeostasis. We have recently shown that in response to hypoxia, HO-1-null mice develop right ventricular infarcts with organized mural thrombi. Furthermore, increased lipid peroxidation and oxidative damage occur in right ventricular cardiomyocytes from HO-1-null but not wild-type mice. 12 Thus, we hypothesized that HO-1 may play a central role in cardiac homeostasis by protecting cardiomyocytes from ischemia/reperfusioninduced injury and secondary oxidative damage. To gain insight into the cardioprotective role of HO-1 in vivo, we generated transgenic mice overexpressing HO-1 specifically in the heart. We measured cardiac performance during ...
To examine the role of heme oxygenase (HO)-1 in the pathophysiology of vascular diseases, we generated mice deficient in both HO-1 and apolipoprotein E (HO-1-/-apoE-/-). Despite similar total plasma cholesterol levels in response to hypercholesterolemia, HO-1-/-apoE-/- mice, in comparison with HO-1+/+apoE-/- mice, had an accelerated and more advanced atherosclerotic lesion formation. In addition to greater lipid accumulation, these advanced lesions from HO-1-/-apoE-/- mice contained macrophages and smooth muscle alpha-actin-positive cells. We further tested the role of HO-1 on neointimal formation in a mouse model of vein graft stenosis. Autologous vein grafts in HO-1-/- mice showed robust neointima consisting of alpha-actin-positive vascular smooth muscle cells (VSMC) 10 days after surgery in comparison to the smaller neointima formed in autologous vein grafts in HO-1+/+ mice. However, at 14 days after surgery, the neointima from composite vessels of HO-1-/- mice was composed mainly of acellular material, indicative of substantial VSMC death. VSMC isolated from HO-1-/- mice were susceptible to oxidant stress, leading to cell death. Our data demonstrate that HO-1 plays an essential protective role in the pathophysiology of atherosclerosis and vein graft stenosis.
These data suggest that the increased mortality during endotoxemia in HO-1(-/-) mice is related to increased oxidative stress and end-organ (renal and hepatic) damage, not to refractory hypotension.
Sepsis is a systemic inflammatory response to a blood-borne infection that is associated with an extremely high rate of morbidity and mortality. The present study investigates the role of cyclooxygenase (COX)-2 in host responses to bacterial endotoxemia. After administration of Escherichia coli lipopolysaccharide, 50% of wild-type mice die within 96 h. COX-2 deficient mice displayed a dramatic improvement in survival with reduced leukocyte infiltration into critical organs (kidneys and lungs) and a blunted and delayed induction of the cytokine inducible genes nitric oxide synthase 2 and heme oxygenase-1. Translocation and activation of transcription factors important for signaling events during an inflammatory response, such as nuclear factor (NF)-kappaB, were also markedly reduced. While the absence of COX-2 did not alter the induction of several pro-inflammatory cytokines in tissue macrophages, induction of the anti-inflammatory cytokine IL-10 was exaggerated. Administration of IL-10 to wild-type mice reduced NF-kappaB activation. Taken together, our data suggest that COX-2 deficient mice are resistant to many of the detrimental consequences of endotoxemia. These beneficial effects occur, in part, by a compensatory increase in IL-10 that counterbalances the pro-inflammatory host response to endotoxemia.
Nitric-oxide synthases (NOS) utilize L-arginine to produce NO, a potent vasodilator that contributes to the regulation of vascular tone. We demonstrated previously that transforming growth factor (TGF)-1 downregulates inducible NOS after its induction by interleukin (IL)-1 by decreasing the rate of inducible NOS gene transcription. In the present study we transfected reporter plasmids containing various lengths of the inducible NOS 5 -flanking region into primary cultured rat aortic smooth muscle cells and stimulated the cells with IL-1 or vehicle. IL-1 increased the activity of the plasmid containing ؊1485 to ؉31 of the inducible NOS gene by more than 10-fold, indicating the presence of IL-1-responsive elements. Further deletion analysis revealed that a construct containing ؊234 to ؉31 of the inducible NOS gene contained the majority of promoter/enhancer activity after IL-1 stimulation. Mutation of the NF-B site within this region partially reduced IL-1-inducible activity; however, a large portion of activity remained independent of the NF-B site. TGF-1 suppressed promoter/enhancer activity after IL-1 stimulation, and this suppression was complete in the construct with a mutated NF-B site. In addition, TGF-1 did not decrease the binding of nuclear proteins to the NF-B site. These data suggest that the ability of TGF-1 to suppress inducible NOS promoter/enhancer activity occurs through a site(s) other than the NF-B motif in vascular smooth muscle cells.
Glycerol-3-phosphate acyltransferase (GPAT) catalyzes the initial and committed step in glycerolipid biosynthesis. Mitochondrial GPAT, unlike the microsomal isozyme, prefers saturated fatty acids as a substrate. We have recently reported cloning of a cDNA to an unidentified 6.8-kb mRNA by a differential hybridization. The mRNA contains an open reading frame of 827 amino acids (p90) with 30% sequence homology in a 300 amino acid stretch to Escherichia coli GPAT. The 6.8-kb mRNA was induced dramatically when fasted mice were refed a high-carbohydrate diet. Here, we have expressed the open reading frame as trpE fusion proteins and used them to generate antibodies. The antibodies recognized a polypeptide of 90 kDa (p90) when the 6.8-kb cDNA sequence was used for in vitro transcription and translation. By Western blot analysis using these antibodies, we detected p90 in mitochondrial fractions
This study identifies a new cause of dominant CMT2 and highlights the importance of TFG in the protein secretory pathways that are essential for proper functioning of the human peripheral nervous system.
Proteins of the LIM family are critical regulators of development and differentiation in various cell types. We have described the cloning of cysteine-rich protein 2/smooth muscle LIM protein (CRP2/SmLIM), a LIM-only protein expressed in differentiated vascular smooth muscle cells. As a first step toward understanding the potential functions of CRP2/SmLIM, we analyzed its expression after gastrulation in developing mice and compared the expression of CRP2/SmLIM with that of the other 2 members of the CRP subclass, CRP1 and CRP3/MLP. In situ hybridization in whole-mount and sectioned embryos showed that CRP2/SmLIM was expressed in the sinus venosus and the 2 cardiac chambers at embryonic day 9. Vascular expression of CRP2/SmLIM was first seen at embryonic day 10. At subsequent time points, CRP2/SmLIM expression decreased in the heart but remained high in the vasculature. CRP1 was expressed both in vascular and nonvascular tissues containing smooth muscle cells, whereas CRP3/MLP was expressed only in tissues containing striated muscle. These patterns of expression were maintained in the adult animal and suggest an important role for this gene family in the development of smooth and striated muscle.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.